Johnson & Johnson: 3 Key Takeaways From The Wells Fargo Healthcare Conference

By Dallas Salazar

Johnson & Johnson (NYSE:JNJ) Chairman of the Board of Directors and Chief Executive Officer Alex Gorsky recently presented at the Wells Fargo 10th Annual Healthcare Conference. Gorsky, whose company is the world’s largest healthcare company and also has market-leading businesses spanning drugs, devices and consumer healthcare, touched on several marquee areas of wonder in what was hosted as a very fireside chat-like presentation.

I believe the commentary given comes a very important time for Johnson & Johnson as it comes just after what was a tough reported earnings period (meaning GAAP – Adjusted financials were indicative of excellent health in my opinion) in which the company faced several headwinds. Some of these headwinds the company has no control over and will not have control over moving forward – these include negative FX impact, global GDP concerns, a growing more volatile global FX environment, patent concerns, etc. Again, any commentary Gorsky gives I believe should be very closely followed and analyzed.

Related Articles

Back to top button